bta ann. is coming., page-9

Street

That is obvious.Its this statement I cant understand they had to make. Its like they dont want BTA shareprice to rise.


''While the positive effect of this expansion on Biota may be significant and GSK have
confirmed it has contracts to supply Relenza to over 60 countries, the announcement
is focussed on increased manufacturing capacity for Relenza, not orders or sales. GSK
has stated that additional regulatory approvals will be required and that the capacity
increases are planned for the end of calendar 2009. The expansion of Relenza capacity
and any increase in resultant royalty payments, will not effect Biota’s cash position until
June 2010, at the earliest.